Mercado global de sufentanil – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de sufentanil

Espera-se que o mercado de sufentanil ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,10% no período de previsão de pesquisa acima mencionado. A investigação, a aprovação da FDA e os produtos em ensaios clínicos de sufentanil são os fatores para o crescimento do mercado de sufentanil.

Por exemplo,

• Em novembro de 2018, a FDA aprovou os comprimidos sublinguais AcelRx Pharmaceuticals, Inc. (30 mg) de sufentanil sob o nome de DSUVIA. O medicamento foi utilizado para o tratamento de dores agudas em adultos.
• O sufentanil intranasal encontra-se em fase IV de ensaio clínico que será utilizado no tratamento da dor aguda pós-traumática. 

O sufentanil é um analgésico opióide que também é utilizado como anestesia durante cirurgias. As propriedades do fármaco são de distribuição e meia-vida mais curtas e são mais potentes e eficazes que o fentanil. É administrado por via epidural, epidural ou sublingual à população adulta, pediátrica e geriátrica. Aproximadamente, 80% da dose administrada é excretada do organismo em 24 horas e apenas 2% da dose é eliminada como medicamento inalterado.  

The rise in medical and gynaecological surgeries may enhance the market growth of sufentanil. In addition, the drug is also used with other drugs to increase the efficacy of the drug. For instance, in one of the case study report, the sufentanil was given along with ropivacaine for the epidural anesthesia and spinal-epidural anesthesia in labor analgesia. The results were concluded that it showed better analgesic activity, decrease the labor onset time and showed fewer side-effects and complications. The sufentanil drug is better than fentanyl analog because it shows higher therapeutic index and highly lipophilic as compared to fentanyl. These properties of sufentanil act as a driver for the sufentanil market growth. The limitation use for some patients or contradictions of these drugs may act as a restraint for the sufentanil market growth. For instance, sufentanil cannot be used for the patients with acute or severe bronchial asthma and patients having gastrointestinal issues. Sufentanil may cause the respiratory depression which may hamper the sufentanil market growth.

This sufentanil market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the sufentanil treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Sufentanil Market Scope and Market Size

The sufentanil market is segmented on the basis of indication, route of administration, drug type, doses, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of indication, the sufentanil market is segmented into opioid analgesic and anaesthetic.
• On the basis of route of administration, the sufentanil market is segmented into intravenous route, epidural route and sublingual route.
• On the basis of drug type, the sufentanil market is segmented into branded and generic.
• On the basis of doses, the sufentanil market is segmented into adult, pediatrics and geriatric.
• On the basis of end users, the sufentanil market is segmented to hospitals, clinics and other.
• On the basis of distribution channel, the sufentanil market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.

Global Sufentanil Market Country Level Analysis

Global sufentanil market is analysed and market size information is provided by country, indication, route of administration, drug type, doses, end users and distribution channel as referenced above.

The countries covered in the sufentanil market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share because it is easily available to healthcare, awareness among the physicians about advanced technological treatment and high healthcare expenditure from the companies and government. Asia-Pacific is considered as the second largest market due to the fastest growth of medical infrastructure, increased medical tourism and high population especially in China which leads to more awareness and usability of the drug.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The sufentanil market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to sufentanil market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the sufentanil market in the growth period.

Competitive Landscape and Sufentanil Market Share Analysis

O panorama competitivo do mercado do sufentanil fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos , pipelines de ensaios clínicos, aprovações de produtos, patentes, largura e amplitude do produto, domínio da aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado do sufentanil.

Os principais players abordados no relatório global do mercado de sufentanil são Wuhan Fengzhulin, Janssen Pharmaceuticals, Cambrex, Mallinckrodt Pharmaceuticals, Hameln Rds, Kern Pharma, Cambrex, Cristalia, Akorn, Inc, Johnson Matthey entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul separadamente. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60570